Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-8 replication by antagonism of the chemokine receptor CXCR4

被引:113
作者
Bridger, GJ
Skerlj, RT
Padmanabhan, S
Martellucci, SA
Henson, GW
Struyf, S
Witvrouw, M
Schols, D
De Clercq, E
机构
[1] AnorMED Inc, Langley, BC V2Y 1N5, Canada
[2] Johnson Matthey Pharmaceut Res, W Chester, PA 19380 USA
[3] Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium
关键词
D O I
10.1021/jm990211i
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Bis-tetraazamacrocycles such as the bicyclam AMD3100 are a class of potent and selective anti-HIV-1 and HIV-2 agents that inhibit virus replication by binding to the chemokine receptor CXCR4, the co-receptor for entry of X4 viruses. With the aim of optimizing the anti-HIV-1 and HIV-2 activity of bis-azamacrocycles, a series of analogues were synthesized which contain neutral heteroatom (oxygen, sulfur) or heteroaromatic (of lower pK(a) than a secondary amine) replacements for the amino groups of AMD3100. The introduction of one or more heteroatoms such as oxygen or sulfur into the macrocyclic ring of p-phenylenebis(methylene)-linked dimers (to give N3X or N2X2 bis-macrocycles) gave analogues with substantially reduced anti-HIV-1 (IIIB) and anti-HIV-2 (ROD) potency. In addition, the bis-sulfur analogue was also markedly more cytotoxic to MT-4 cells. However, bis-tetraazamacrocycles featuring a single pyridine group incorporated within the macrocyclic framework: exhibited anti-HIV-l and HIV-2 potency comparable to that of their saturated, aliphatic counterparts. The p-phenylenebis(methylene)-linked dimer of the py[14]aneN(4) macrocycle inhibited HIV-1 replication at a 50% effective concentration (EC50) of 0.5 mu M while remaining nontoxic to MT-4 cells at concentrations approaching 200 mu M. A series of analogues containing macrocyclic heteroaromatic groups of varying pK(a) were also synthesized, and their ability to inhibit HN replication was evaluated. Replacing the pyridine moiety of the py[14]aneN(4) macrocyclic ring with pyrazine or pyridine groups substituted in the 4-position (with electron-withdrawing or -donating groups) either reduced antiviral potency or increased cytotoxicity to MT-4 cells. Finally, we synthesized a series of analogues in which the ring size of the bis-pyridyl macrocycles was varied between 12 and 16 members per ring including the py[iso-14]aneN(4) ring system, an isomer of the py[14]aneN(4) macrocycle. The p-phenylenebis(methylene)-linked dimer of the py[iso-14]aneN4 (AMD3329) displayed the highest antiviral activity of the bis-azamacrocyclic analogues reported to date, exhibiting EC50's against the cytopathic effects of HIV-1 and HIV-2 replication of 0.8 and 1.6 nM, respectively, that is, about 3-5-fold lower than the EC50 Of AMD3100. AMD3329 also inhibited the binding of a specific CXCR4 mAb and the Ca2+ flux induced by SDF-1 alpha, the natural ligand for CXCR4, more potently than AMD3100. Furthermore, AMD3329 also interfered with virus-induced syncytium formation at an EC50 Of 12 nM.
引用
收藏
页码:3971 / 3981
页数:11
相关论文
共 21 条
[1]   Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit human immunodeficiency virus replication .2. Effect of heteroaromatic linkers on the activity of bicyclams [J].
Bridger, GJ ;
Skerlj, RT ;
Padmanabhan, S ;
Martellucci, SA ;
Henson, GW ;
Abrams, MJ ;
Joao, HC ;
Witvrouw, M ;
DeVreese, K ;
Pauwels, R ;
DeClercq, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) :109-119
[2]   SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF PHENYLENEBIS(METHYLENE)-LINKED BIS-TETRAAZAMACROCYCLES THAT INHIBIT HIV REPLICATION - EFFECTS OF MACROCYCLIC RING SIZE AND SUBSTITUENTS ON THE AROMATIC LINKER [J].
BRIDGER, GJ ;
SKERLJ, RT ;
THORNTON, D ;
PADMANABHAN, S ;
MARTELLUCCI, SA ;
HENSON, GW ;
ABRAMS, MJ ;
YAMAMOTO, N ;
DEVREESE, K ;
PAUWELS, R ;
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (02) :366-378
[3]   A versatile intermediate for the preparation of c-functionalized azamacrocycles and application to the synthesis of the potent Anti-HIV agent (+/-)JM2936 [J].
Bridger, GJ ;
Skerlj, RT ;
Padmanabhan, S ;
Thornton, D .
JOURNAL OF ORGANIC CHEMISTRY, 1996, 61 (04) :1519-1522
[4]   METAL-COMPLEXES OF MACROCYCLIC LIGANDS CONTAINING PYRIDINE [J].
COSTA, J ;
DELGADO, R .
INORGANIC CHEMISTRY, 1993, 32 (23) :5257-5265
[5]   Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry [J].
Datema, R ;
Rabin, L ;
Hincenbergs, M ;
Moreno, MB ;
Warren, S ;
Linquist, V ;
Rosenwirth, B ;
Seifert, J ;
McCune, JM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :750-754
[6]   HIGHLY POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY THE BICYCLAM DERIVATIVE JM3100 [J].
DE CLERCQ, E ;
YAMAMOTO, N ;
PAUWELS, R ;
BALZARINI, J ;
WITVROUW, M ;
DEVREESE, K ;
DEBYSER, Z ;
ROSENWIRTH, B ;
PEICHL, P ;
DATEMA, R ;
THORNTON, D ;
SKERLJ, R ;
GAUL, F ;
PADMANABHAN, S ;
BRIDGER, G ;
HENSON, G ;
ABRAMS, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :668-674
[7]   POTENT AND SELECTIVE-INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-1 AND HIV-2 REPLICATION BY A CLASS OF BICYCLAMS INTERACTING WITH A VIRAL UNCOATING EVENT [J].
DECLERCO, E ;
YAMAMOTO, N ;
PAUWELS, R ;
BABA, M ;
SCHOLS, D ;
NAKASHIMA, H ;
BALZARINI, J ;
DEBYSER, Z ;
MURRER, BA ;
SCHWARTZ, D ;
THORNTON, D ;
BRIDGER, G ;
FRICKER, S ;
HENSON, G ;
ABRAMS, M ;
PICKER, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5286-5290
[8]   TOWARD IMPROVED ANTI-HIV CHEMOTHERAPY - THERAPEUTIC STRATEGIES FOR INTERVENTION WITH HIV-INFECTIONS [J].
DECLERCQ, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (14) :2491-2517
[9]   The bicyclams, a new class of potent human immunodeficiency virus inhibitors, block viral entry after binding [J].
DeVreese, K ;
Reymen, D ;
Griffin, P ;
Steinkasserer, A ;
Werner, G ;
Bridger, GJ ;
Este, J ;
James, W ;
Henson, GW ;
Desmyter, J ;
Anne, J ;
DeClercq, E .
ANTIVIRAL RESEARCH, 1996, 29 (2-3) :209-219
[10]   AMD310, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor [J].
Donzella, GA ;
Schols, D ;
Lin, SW ;
Esté, JA ;
Nagashima, KA ;
Maddon, PJ ;
Allaway, GP ;
Sakmar, TP ;
Henson, G ;
De Clercq, E ;
Moore, JP .
NATURE MEDICINE, 1998, 4 (01) :72-77